Insight Molecular Diagnostics Total Assets 2014-2025 | IMDX

Insight Molecular Diagnostics total assets from 2014 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Insight Molecular Diagnostics Total Assets 2014-2025 | IMDX

Insight Molecular Diagnostics total assets from 2014 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.2B
Doximity (DOCS)$11.7B
Hims & Hers Health (HIMS)$11.6B
Tempus AI (TEM)$10.4B
IRhythm Technologies (IRTC)$4.4B
Inspire Medical Systems (INSP)$3.8B
Hinge Health (HNGE)$3.7B
Privia Health (PRVA)$2.5B
Enovis (ENOV)$1.7B
Phreesia (PHR)$1.6B
Schrodinger (SDGR)$1.6B
Clover Health Investments (CLOV)$1.5B
10x Genomics (TXG)$1.5B
Azenta (AZTA)$1.5B
Evolent Health (EVH)$1.3B
Omnicell (OMCL)$1.3B
Claritev (CTEV)$725M
Fulgent Genetics (FLGT)$549M
Veradigm (MDRX)$499M
Standard BioTools (LAB)$471M
Butterfly Network (BFLY)$443M
Talkspace (TALK)$416M
TruBridge (TBRG)$326M
Outset Medical (OM)$321M
Nyxoah SA (NYXH)$271M
Health Catalyst (HCAT)$264M
SOPHiA GENETICS SA (SOPH)$241M
CapsoVision (CV)$221M
Zepp Health (ZEPP)$188M
KORU Medical Systems (KRMD)$144M